6,364 press releases indexed under healthcare.
Frederick-area businesses push annual fundraiser for Frederick Health Hospice toward its $5,000 goal FREDERICK, Md., Aug. 25, 2026 /PRNewswire/ -- American Iron Speed-n-Cycle has raised more than $4,000 for Frederick Health Hospice through community sponsorships for the 2nd Annual Miles...
MINNEAPOLIS, August 25, 2026--Padilla names new Health sector leaders, strengthening its integrated expertise and positioning the agency for continued growth.
(PR-inside.com) Federal courts are confronting allegations that major MSOs marketed recreational cannabis as medicine without FDA clinical trials, while MMJ's cases challenge a system that penalized the company that followed the federal drug-development pathway. WASHINGTON, D.C. / ACCESS Newswire / August 25, 2026 / MMJ International Holdings today called attention to a rapidly developing collision between federal marijuana policy, unsupported medical marketing allegations and insurance coverage that could have consequences across the cannabis industry. As DEA Administrative Law Judge Derek C. Julius considers his recommendation in the federal marijuana-rescheduling proceeding-and federal courts consider MMJ-related challenges-major cannabis multistate operators are facing proposed class a
Federal courts are confronting allegations that major MSOs marketed recreational cannabis as medicine without FDA clinical trials, while MMJ's cases challenge a system that penalized the company that followed the federal drug-development pathway.
Clinical-Stage Biotechnology Company Is Preparing a Phase 2a Trial of Nu-3, a Topical Bisphosphocin® Gel, in Infected Diabetic Foot Ulcers B2i Digital Campaign to Center on Nu-3, the Upcoming Phase 2a Trial, and the Bisphosphocin® Class Behind It NEW YORK, NY - August 25, 2026 ( NEWMEDIAWIRE ) - B2i Digital, Inc. today welcomed Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) as its newest Featured Company. The Sarasota, Florida clinical-stage biotechnology company develops the Bisphosphocin® class, a novel group of fast-acting, broad-spectrum antimicrobials for infectious diseases and antibiotic-resistant bacterial strains, and B2i Digital will bring that work, and the clinical program built around it, to its network of retail and institutional market participants. A full company profi
KING OF PRUSSIA, Pa., Aug. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the following conferences: September 8, 2026, at 8:45am ET at the Wells Fargo Healthcare Conference September 14, 2026, at 8:30am ET at the Morgan Stanley Global...
BELLAIRE, Texas, Aug. 25, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Susan K. Sparkman, MD is acknowledged as a 2026 Legacy Achiever for her contributions to Psychiatry and Integrative Mental Health. Dr. Susan K. Sparkman has established a remarkable legacy in...
MUNICH, GERMANY - August 25, 2026 ( NEWMEDIAWIRE ) - Novogenia AG (ticker symbol: 7V0, formerly Darwin AG), an international healthcare company focused on human genetics and the development of personalized products based on genetic insights, announces the U.S. market launch of its new MGT Plus methylation test. With this launch, Novogenia and its U.S. partner 10X Health are further expanding their joint product pipeline and strengthening their international collaboration in the field of innovative genetic analysis and longevity. Methylation is a fundamental biochemical process involved in numerous metabolic and regulatory processes in the human body. As an integral part of key metabolic pathways, it can significantly influence the function and processing of a wide range of biological molec
REXBURG, Idaho, Aug. 25, 2026 /PRNewswire/ -- How do patients know whether their injury qualifies as medical malpractice under Idaho law? A HelloNation article featuring Medical Malpractice Attorneys Marcia Murdoch and Steven Atkinson of Barton Atkinson & Murdoch, P.C. offers a clear...
Forbes recognizes Tampa General as the highest-ranked healthcare and social services employer in the Tampa Bay region, reflecting its commitment to helping women build careers, advance into leadership and thrive at every stage of life. TAMPA, Fla., Aug. 25, 2026 /PRNewswire/ -- Tampa...
SAN DIEGO, August 25, 2026--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that management is scheduled to present at the 2026 Morgan Stanley Global Healthcare Conference on Tuesday, September 15th at 5:35 p.m. ET.
The company's investment will expand access to Pear Suite technology that streamlines service documentation, referrals and Medi-Cal reimbursement for community health worker and doula services. LOS ANGELES, Aug. 25, 2026 /PRNewswire/ -- Health Net, one of California's most experienced...